Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.1050
0.00 (0.00%)
Sep 17, 2026, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 99.21 million as of September 17, 2026. Its market cap has decreased by -27.86% in one year.
Market Cap
99.21M
Enterprise Value
85.49M
Revenue
19.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 99.21M, a decrease of -49.56%. That is a compound annual growth rate of -12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 99.21M | -55.78% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 207.14M |
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 102.07M |
| SomnoMed | 73.62M |
| Epiminder | 60.67M |
| Cyclopharm | 60.35M |
| Compumedics | 46.94M |